Researchers from the Mitochondrial Medicine Program at Children's Hospital of Philadelphia (CHOP) have better characterized a ...
The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.
This is a developing news story. Please check back soon for updates. Seonix Bio launched SightScore, a polygenic risk score ...
The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.
New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects.
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...
Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...
It might sound hyperbolic to say that finding even one female turtle can revive an entire species. However, nothing could be ...
Partnership to Launch DNA-Based Colorectal Cancer Screening TestBERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback